logo image
search icon
Non-Invasive Respiratory Therapy Market

Non-Invasive Respiratory Therapy Market Size, Share & Trends Analysis Report By Product (Non-invasive Positive-pressure Ventilator (PPV), Non-invasive Negative Pressure Ventilator (NPV)), By Application (Respiratory Distress Syndrome, Asthma & COPD, Others), By End-Use, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2198 | Published : 2024-03-07 | Pages: 180 | Format: PDF/EXCEL

Non-Invasive Respiratory Therapy Market Size is valued at USD 2.36 Bn in 2023 and is predicted to reach USD 3.61 Bn by the year 2031 at a 5.57% CAGR during the forecast period for 2024-2031. 

Non-Invasive Respiratory Therapy

Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma, sleep apnea, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (ARDS). Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. Continuous technological breakthroughs have resulted in the creation of more efficient, user-friendly, and portable non-invasive respiratory equipment.

Smart inhalers, wearable gadgets, and telemedicine solutions improve the patient experience and adherence to therapy. Factors such as rising respiratory illnesses and a surge in demand for non-invasive procedures are expected to drive market expansion in the coming years. Furthermore, benefits connected with various non-invasive (NIV) ventilators are other variables related to increased device acceptance and market expansion.

However, the emergence of the COVID-19 pandemic had a substantial impact on the market under consideration. Because of the pandemic's abrupt onset, the market saw a short-term negative impact due to decreased patient visits to hospitals and clinics. However, in the later stages of the pandemic, the market experienced tremendous growth due to increasing demand for NIV for COVID-19 patients and other chronic respiratory illness patients.

Competitive Landscape

Some Major Key Players In The Non-Invasive Respiratory Therapy Market:

  • ResMed Inc.
  • Teleflex Incorporated
  • Hamilton Medical
  • Koninklijke Philips N.V.
  • Heyer Medical AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Airon Corporation
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • Baxter International Inc.
  • WILAmed GmbH
  • Getinge AB
  • Others

Market Segmentation:

The Non-Invasive Respiratory Therapy Market is segmented on the basis of product, application, and end-use. As per the product, the market is divided into Non-invasive Positive-pressure Ventilator (PPV) and non-invasive Negative Pressure Ventilator (NPV). The Positive-pressure Ventilator (PPV) segment includes Bi-level Positive Airway Pressure Ventilator (BiPAP), Constant Positive Airway Pressure Ventilator (CPAP), and Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP). According to the application, the market consists of Asthma & Chronic Obstructive Pulmonary Disease (COPD), respiratory distress syndrome, and Others. The end-user segment includes Hospitals, Ambulatory Surgical Centers (ASCs), and Others.

Based On The Positive-Pressure Ventilator (PPV), The Constant Positive Airway Pressure Ventilator (CPAP) Segment Is Accounted As A Major Contributor In The Non-Invasive Respiratory Therapy Market. 

The Constant Positive Airway Pressure Ventilator (CPAP) category is expected to hold a major share in the global Non-Invasive Respiratory Therapy Market in 2024. This is due to the fact that Continuous Positive Airway Pressure (CPAP) is a type of positive airway pressure used to maintain a constant pressure during both inspiration and expiration. The use of CPAP preserves PEEP, reduces atelectasis, increases alveolar surface area, improves Ventilation/Perfusion (V/Q) matching, and hence improves oxygenation. While CPAP alone is frequently insufficient for sustaining ventilation, extra pressure support during inspiration in the form of Inspiratory Positive Airway Pressure (IPAP) or Bilevel Positive Airway Pressure (BiPAP) for non-invasive ventilation is required.

Asthma & Chronic Obstructive Pulmonary Disease (COPD) Segment Witnessed Growth At A Rapid Rate.

The Asthma & Chronic Obstructive Pulmonary Disease (COPD) segment is projected to rapid growth in the global Non-Invasive Respiratory Therapy Market. Asthma and COPD problems are becoming more common, which has contributed to the rise in their prevalence. According to the WHO, COPD is the world's third leading reason of death, accounting for 3.23 million fatalities. Low- and middle-income countries (LMIC) account for around 90% of COPD fatalities among people under the age of 70. Tobacco use is responsible for more than 70% of COPD cases in high-income nations and 30%-40% of COPD cases in low- and middle-income countries, with household air pollution being a major risk factor. Furthermore, new product launches by prominent companies are projected to boost revenue growth in this market.

In The Region, The North America Non-Invasive Respiratory Therapy Market Holds A Significant Revenue Share.

The North American non-invasive Respiratory Therapy Market is expected to record the maximum market revenue share in the near future, attributed to the increased frequency of respiratory illnesses. The market in the United States will account for the highest share in 2024, owing to technical improvements in non-invasive ventilators and the rising frequency of respiratory illnesses. According to the American Lung Association, approximately 34 million Americans are affected by chronic respiratory disorders, which include asthma and COPD, as well as emphysema and chronic bronchitis. Furthermore, new technical breakthroughs in mechanical ventilators will likely fuel this region's market revenue growth throughout the projection period. Moreover, Europe is expected to grow significantly within the forecast period. This is because of the rising incidence of respiratory illnesses and technological developments in non-invasive ventilators, as well as the country's rising prevalence of sleep apnea.

Recent Developments:

  • In June 2021, Medline Industries, Inc. ("Medline") acquired a substantial portion of Teleflex Incorporated's Respiratory business for $286 million in cash, less $12 million in working capital not transferred to Medline. The divestiture was finalized by Teleflex Incorporated, a leading global provider of healthcare supplies and services.
  • In Nov 2020, Philips released a brand-new non-invasive ventilator specially made for people with COPD. With the Philips Ventilator BiPAP A40 EFL, healthcare professionals could easily check for and find expiratory flow limitation (EFL) to get the best homecare therapy.

Non-Invasive Respiratory Therapy Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 2.36 Bn

Revenue Forecast In 2031

USD 3.61 Bn

Growth Rate CAGR

CAGR of 5.57 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Application, Product, End-Use

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

ResMed Inc., Teleflex Incorporated, Hamilton Medical, Koninklijke Philips N.V., Heyer Medical AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Airon Corporation, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Baxter International Inc., WILAmed GmbH, Getinge AB, and others.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Non-Invasive Respiratory Therapy Market Snapshot

Chapter 4. Global Non-Invasive Respiratory Therapy Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Product, & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:

5.2.1. Non-invasive Positive-pressure Ventilator (PPV)

5.2.1.1. Bi-level Positive Airway Pressure Ventilator (BiPAP)

5.2.1.2. Constant Positive Airway Pressure Ventilator (CPAP)

5.2.1.3. Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)

5.2.2. Non-invasive Negative-pressure Ventilator (PPV)

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

6.2.1. Respiratory Distress Syndrome

6.2.2. Asthma & Chronic Obstructive Pulmonary Disease (COPD)

6.2.3. Others

Chapter 7. Market Segmentation 3: By End-use Estimates & Trend Analysis

7.1. By End-use & Market Share, 2019 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-use:

7.2.1. Hospitals

7.2.2. Ambulatory Surgical Centers (ASCs)

7.2.3. Others

Chapter 8. Non-Invasive Respiratory Therapy Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031

8.1.2. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031

8.1.3. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By End-use, 2024-2031

8.1.4. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2024-2031

8.2.2. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2024-2031

8.2.3. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2024-2031

8.2.4. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2024-2031

8.3.2. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2024-2031

8.3.3. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2024-2031

8.3.4. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2024-2031

8.4.2. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2024-2031

8.4.3. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031

8.4.4. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2024-2031

8.5.2. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2024-2031

8.5.3. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031

8.5.4. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. ResMed Inc.

9.2.2. Teleflex Incorporated

9.2.3. Hamilton Medical

9.2.4. Koninklijke Philips N.V.

9.2.5. Heyer Medical AG

9.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

9.2.7. Airon Corporation, Drägerwerk AG & Co. KGaA

9.2.8. Fisher & Paykel Healthcare Limited

9.2.9. Baxter International

9.2.10. WILAmed GmbH

9.2.11. Getinge AB  

Segmentation of Non-Invasive Respiratory Therapy Market-

Non-Invasive Respiratory Therapy Market By Product-

  • Non-invasive Positive-pressure Ventilator (PPV)
    • Bi-level Positive Airway Pressure Ventilator (BiPAP)
    • Constant Positive Airway Pressure Ventilator (CPAP)
    • Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)
  • Non-invasive Negative Pressure Ventilator (NPV) 

Non-Invasive Respiratory Therapy

Non-Invasive Respiratory Therapy Market By Application-

  • Respiratory Distress Syndrome
  • Asthma & COPD
  • Others

Non-Invasive Respiratory Therapy Market By End-Use-

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Non-Invasive Respiratory Therapy Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Non-Invasive Respiratory Therapy Market?

Non-Invasive Respiratory Therapy Market expected to grow at a 5.57% CAGR during the forecast period for 2024-2031.

Dr├Ągerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Baxter International Inc., WILAmed GmbH, Getinge AB, and others.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach